AI assistant
MetaVia Inc. — Director's Dealing 2020
Jan 10, 2020
34919_dirs_2020-01-09_9e5abea2-a9cf-418a-b8f4-5f290d66a2d0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NeuroBo Pharmaceuticals, Inc. (NRBO)
CIK: 0001638287
Period of Report: 2019-12-30
Reporting Person: E&Investment, Inc. (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4335800 | Indirect |
| Common Stock | 1121190 | Indirect |
| Common Stock | 1864799 | Indirect |
Footnotes
F1: These shares are owned directly by The E&Healthcare Investment Fund II, a 10% owner of the Issuer, and indirectly by E&Investment, Inc., as sole general partner of The E&Healthcare Investment Fund II.
F2: These shares are owned directly by The E&Healthcare Investment Fund No. 6, and indirectly by E&Investment, Inc., as sole general partner of The E&Healthcare Investment Fund No. 6
F3: These shares are owned directly by The E&Healthcare Investment Fund No.7, a 10% owner of the Issuer, and indirectly by E&Investment, Inc., as sole general partner of The E&Healthcare Investment Fund No.7.
F4: E&Investment, Inc. disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.